Allergy Therapeutics (AGY) News Today → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free AGY Stock Alerts GBX 3.20 +0.05 (+1.59%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | markets.businessinsider.comBuy Rating Justified for Aquestive Therapeutics Amidst Innovative Allergy Treatment and Strong Financial ProspectsMay 9, 2024 | tmcnet.comGlobal Skin Allergy Testing Market Expected to Reach $771.5 Million by 2028May 2, 2024 | msn.comSkin patch improves treatment for pediatric milk allergiesApril 27, 2024 | businesswire.comGlobal Skin Allergy Testing Market Report 2024: Revenue Data for 2020-2022, Estimated Figures for 2023, and Forecasts for 2028 - ResearchAndMarkets.comApril 18, 2024 | dailymail.co.ukThe most common 'inhalant' allergiesMarch 29, 2024 | finance.yahoo.comAllergy Therapeutics First Half 2024 Earnings: UK£0.006 loss per share (vs UK£0.013 loss in 1H 2023)March 28, 2024 | lse.co.ukAIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenueMarch 2, 2024 | finance.yahoo.comAllergy Therapeutics plc (AGY.L)November 8, 2023 | morningstar.comAllergy Therapeutics PLC AGYNovember 6, 2023 | marketwatch.comAllergy Therapeutics Extends Cash Runway to End of YearOctober 14, 2023 | finance.yahoo.comAllergy Therapeutics (LON:AGY) dips 10.0% this week as increasing losses might not be inspiring confidence among its investorsOctober 13, 2023 | marketwatch.comAllergy Therapeutics to Raise GBP40.75 Mln; Mandatory Cash Offer TriggeredJuly 31, 2023 | abcnews.go.comRed meat allergy caused by ticks is an 'emerging public health concern': CDCJune 22, 2023 | forbes.comWhat Is A Mold Allergy? Symptoms, Causes And TreatmentsJune 19, 2023 | marketwatch.comAllergy Therapeutics Shares Fall on Going Concern UncertaintyJune 14, 2023 | technews.tmcnet.comGenerational Equity Advises Allergy, Sinus & Asthma Family Health Center in its Sale to AllerVie HealthJune 12, 2023 | msn.comIntellia Therapeutics stock gains on CRISPR treatment resultsJune 12, 2023 | msn.comWhy Intellia Therapeutics Stock Is Rising MondayJune 9, 2023 | proactiveinvestors.comAllergy Therapeutics to present key scientific findings from its research portfolioMay 26, 2023 | benzinga.comGlobal Allergy Immunotherapies Market Report 2023: Growing Consumer Awareness Towards Health Benefits of Allergy Immunotherapies Fuels the SectorMay 9, 2023 | marketwatch.comGlobal Food Allergy Diagnostics And Therapeutics Market Increasing Demand with Leading Player, Comprehensive Analysis, Forecast 2030May 5, 2023 | marketwatch.comPeanut Allergy Therapeutics Market Projected to Reach Significant Growth Value by 2030April 19, 2023 | proactiveinvestors.comAllergy Therapeutics peanut vaccine candidate negotiates its early clinical hurdleApril 11, 2023 | finance.yahoo.comForm 8.3 - The Allergy Therapeutics PlcApril 7, 2023 | forbes.comNasal Spray For Allergies: What You Need To KnowMarch 29, 2023 | usatoday.comSpring is here—here’s what you need to survive seasonal allergiesMarch 29, 2023 | marketwatch.comGlobal Mugwort Pollen and Allergies Therapeutics Drug Market : Latest Report 2029March 28, 2023 | marketwatch.com2023 Allergy Treatment Market: Best Practices of Top Players and Business Success Plans till 2030March 28, 2023 | marketwatch.comAllergy Diagnostics And Therapeutics Market by 2031March 27, 2023 | abcnews.go.comWhat Kind Of Doctor Treats Allergies, And How Do I Know Which One I Should See?March 27, 2023 | proactiveinvestors.comAllergy Therapeutics doses first patients with peanut allergy vaccineMarch 19, 2023 | usatoday.comSpring arrives weeks early, bringing sniffling and sneezing to allergy sufferersMarch 17, 2023 | marketwatch.comAllergy Diagnostics and Therapeutics Market with Top Market Players till 2029March 16, 2023 | marketwatch.comLatest "Allergy Treatment Market" to Register Strong Growth of CAGR to 2029March 15, 2023 | marketwatch.comAllergy Immunotherapies Market : Key Trends and Opportunities by State and Territory to 2029March 11, 2023 | marketwatch.comGlobal Eye Allergy Therapeutics Market Global Segments, Size, Recent Trends Till Forecast 2030 By VMReportsMarch 10, 2023 | marketwatch.comGlobal Allergy Immunotherapies Market 2023 Dynamics, Major Players, SWOT Analysis, and Business Forecast to 2030 By VMReportsFebruary 22, 2023 | marketwatch.comFuture of Allergy Immunotherapies Market 2023: Comprehensive Study and Industry Trends till 2028February 20, 2023 | marketwatch.comAllergy Immunotherapy Market Set for Huge Industry Growth by 2026| Reports and DataFebruary 16, 2023 | forbes.comBest Eye Drops For Allergies Of 2023, According To ExpertsFebruary 14, 2023 | marketwatch.comAllergy Diagnostics and Therapeutics Market (New Research Report) Substantial Growth, Revenues, Service with Forecast to 2028February 3, 2023 | marketwatch.comGlobal Allergy Medicine Market Size 2023 Research Report by Growth, Development, Revenue, Future Analysis, Business Prospects and Forecast to 2028January 27, 2023 | yahoo.comGlobal Food Allergy Diagnostics & Therapeutics Market 2022 - 2027: Featuring Allergy Therapeutics, Astra Biotech, Biomerieux and Danaher Among OthersJanuary 18, 2023 | benzinga.comRhinitis Pipeline Appears Robust With 32+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightJanuary 5, 2023 | marketwatch.comEgg Allergy Therapeutics market Size Research Report 2023 by Size, Shares, CAGR Status, Industry Segments with Key Players Forecast to 2028December 28, 2022 | marketwatch.comGlobal Allergy Shots Market Growth 2023: Research by Industry Scope, Demand Scenario, Competitive Landscape, Size and Share Forecast by 2028December 23, 2022 | marketwatch.comAllergy Treatment Market Size and Forecast To 2028 | 96 Pages ReportDecember 20, 2022 | marketwatch.comAllergy Immunotherapy Market Trend Analysis, Huge Demand, Opportunity Assessment, Emerging Technologies and Revenue Expectation 2023 to 2027December 17, 2022 | marketwatch.comAllergy Treatment Market : Latest Trends, Size, Key Players, Revenue and Forecast 2028December 17, 2022 | marketwatch.comMarket Research Report: Future Trends in the Food Allergy Diagnosis and Treatment Industry 2022 to 2028. Get Allergy Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history. Watch his stock warning right here, 100% free of charge AGY Media Mentions By Week AGY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGY News Sentiment▼0.860.55▲Average Medical News Sentiment AGY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGY Articles This Week▼20▲AGY Articles Average Week Get Allergy Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANCR News Today APH News Today EAH News Today CEL News Today VLG News Today EKF News Today AVCT News Today FARN News Today CREO News Today FUM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AGY) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.